InsidersTradesSigma
Track the 力生制药 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). The latest transaction was reported on 4 August 2026 (Purchase). Among the most active insiders: 郭晓燕. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
力生制药 es una empresa centrada en la investigación, desarrollo y fabricación de productos farmacéuticos en China. Se especializa en tratamientos para diversas enfermedades y afecciones médicas.